deltaDOT selected to aid 'the accelerated manufacture of pharmaceuticals'
UK-based deltaDOT has been given a key role providing analytical technologies to a consortium aiming to increase the efficiency of vaccine and biological drug production.
Archives for July 16, 2007
Single-shot vaccines on the horizon
Research being carried out at the University of Utrecht in the Netherlands to replace standard vaccination schedules with a single-shot alternative could do away with the need for repeated jabs.
AstraZeneca and IBM re-ink mammoth outsourcing deal
Computer giant IBM has re-inked a huge $1.4bn (€1.0bn) IT outsourcing deal with drug giant AstraZeneca, who is continuing its cost-cutting drive to become 'lean and agile'.
Asia becoming important Phase I player
Phase I development in Asia is becoming very important, delegates heard at the recent Drug Information Association (DIA) meeting in Atlanta.
Expansion of allergen material facility
Biopol Laboratory is acting to meet the demand of sneezes, itchy eyes and running noses as it consolidates its five allergen production facilities into one main building in Idaho.
VGX strengthens its plasmid position
US biopharmaceutical company VGX has strengthened its position in the plasmid DNA area with the award of two new patents covering the use and manufacture of plasmid DNA.